STOCK TITAN

OneMedNet (NASDAQ: ONMD) clears Nasdaq $1 minimum bid hurdle

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

OneMedNet Corporation reported that it has regained compliance with Nasdaq’s minimum bid price requirement for continued listing on The Nasdaq Capital Market. Nasdaq staff notified the company that, for 10 consecutive business days from September 24, 2025 through October 7, 2025, the closing bid price of its common stock was at least $1.00 per share, satisfying Nasdaq Listing Rule 5550(a)(2). With this notice, the prior bid price deficiency has been resolved and the listing compliance matter is now closed.

Positive

  • Nasdaq compliance restored: The company has regained compliance with Nasdaq Listing Rule 5550(a)(2) after maintaining a closing bid price of at least $1.00 for 10 consecutive business days, closing out a prior delisting risk tied to this rule.

Negative

  • None.

Insights

Nasdaq bid-price compliance removes an immediate delisting overhang.

OneMedNet Corporation confirms its common stock again meets Nasdaq’s $1.00 minimum bid requirement. Nasdaq staff documented that the shares closed at or above $1.00 for 10 consecutive business days from September 24, 2025 through October 7, 2025, which restores compliance with Listing Rule 5550(a)(2).

This development closes a previously disclosed deficiency that could have led to delisting from The Nasdaq Capital Market if not cured. Maintaining a Nasdaq listing can be important for trading liquidity and for some institutional investors that require listings on major U.S. exchanges.

The matter is described as closed by Nasdaq staff, so no further immediate remedial actions are indicated in this notice. Future trading performance of the stock will determine whether the company continues to satisfy Nasdaq’s bid price rule over time.

false 0001849380 0001849380 2025-10-08 2025-10-08 0001849380 ONMD:CommonStock0.0001ParValuePerShareMember 2025-10-08 2025-10-08 0001849380 ONMD:RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember 2025-10-08 2025-10-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): October 8, 2025

 

ONEMEDNET CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware   001-40386   86-2076743

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

6385 Old Shady Oak Road, Suite 250

Eden Prairie, MN 55344

(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: 800-918-7189

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value per share   ONMD   The Nasdaq Stock Market LLC
         
Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share   ONMDW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 8.01. Other Events.

 

As previously disclosed, on April 10, 2025, OneMedNet Corporation (the “Company”) received a letter from the staff of the Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it was not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”), and providing a grace period until October 7, 2025 to regain compliance.

 

On October 8, 2025, the Company received written notice (the “Notice”) from the Staff indicating that the Company has regained compliance with the Bid Price Rule. The Notice states that for 10 consecutive business days from September 24, 2025 through October 7, 2025, the closing bid price of the Company’s common stock was at least $1.00 per share. Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), and this matter is now closed.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: October 9, 2025

 

  ONEMEDNET CORPORATION
     
  By: /s/ Aaron Green
    Aaron Green
    Chief Executive Officer

 

 

 

 

 

FAQ

What did OneMedNet Corporation (ONMD) announce in this 8-K?

OneMedNet Corporation announced that Nasdaq staff notified the company it has regained compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), and that the related listing matter is now closed.

Why was OneMedNet Corporation (ONMD) previously out of compliance with Nasdaq rules?

On April 10, 2025, the company received a letter from Nasdaq’s Listing Qualifications staff stating that its common stock did not meet the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market, triggering a compliance grace period through October 7, 2025.

How did OneMedNet (ONMD) regain compliance with the Nasdaq minimum bid price rule?

Nasdaq’s notice states that from September 24, 2025 through October 7, 2025, the closing bid price of OneMedNet’s common stock was at least $1.00 per share for 10 consecutive business days, satisfying the minimum bid price requirement.

What Nasdaq listing rule is involved for OneMedNet Corporation (ONMD)?

The matter concerns Nasdaq Listing Rule 5550(a)(2), often called the Bid Price Rule, which requires a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market.

What does it mean that the Nasdaq compliance matter for OneMedNet is now closed?

Nasdaq’s written notice states that the company has regained compliance with the Bid Price Rule, so the prior deficiency related to the minimum bid price has been resolved and the listing qualifications matter is considered closed.

Which securities of OneMedNet are listed on Nasdaq?

The company lists its common stock, $0.0001 par value per share, under the symbol ONMD, and its redeemable warrants, each exercisable for one share of common stock at an $11.50 exercise price, under the symbol ONMDW on The Nasdaq Stock Market LLC.
OneMedNet

NASDAQ:ONMD

View ONMD Stock Overview

ONMD Rankings

ONMD Latest News

ONMD Latest SEC Filings

ONMD Stock Data

40.00M
14.67M
Health Information Services
Services-commercial Physical & Biological Research
Link
United States
SURREY